Selective cleavage of nucleolar autoantigen B23 by granzyme B in differentiated vascular smooth muscle cells: Insights into the association of specific autoantibodies with distinct disease phenotypes
Abstract:Objective. To investigate the association of specific autoantibodies with distinct disease phenotypes. The association of autoantibodies to nucleophosmin/ B23 with pulmonary hypertension in scleroderma, and the susceptibility of autoantigens to cleavage by granzyme B (GB), provided a focus for these studies.Methods. Intact cells were subjected to cytotoxic lymphocyte granule-induced death, and the susceptibility of autoantigens to cleavage by GB was addressed by immunoblotting and/or by a novel immunofluoresce… Show more
“…Among those reported are various MMPs (17)(18)(19) and plasmin reductase (20,21). Granzyme B, a serine protease found in T cell granules, is strikingly associated with cleavage of autoantigens targeted by autoantibodies in patients with SSc (33,56). In agreement with this hypothesis, we demonstrated that both granzyme B and the full granule content could indeed cleave plasminogen into varioussized fragments containing angiostatin K [1][2][3] .…”
Section: Discussionsupporting
confidence: 63%
“…Although several proteases can potentially cleave plasminogen in a manner that would lead to angiostatin production, granzyme B is a particularly interesting candidate given its high levels in the peripheral blood cells of some patients with SSc (32,33). To determine whether granzyme B can cleave plasminogen, SSc and control plasma samples were allowed to interact with granzyme B or the entire granule content (the source of granzyme B) in vitro ( Figure 2C).…”
Section: Angiogenesis Inhibitors In Systemic Sclerosis 3451mentioning
Objective. Systemic sclerosis (SSc; scleroderma) is a systemic connective tissue disease with an extensive vascular component that includes aberrant microvasculature and impaired wound healing. The aim of this study was to investigate the presence of antiangiogenic factors in patients with SSc.Methods. Plasma samples were obtained from 30 patients with SSc and from 10 control patients without SSc. The samples were analyzed for the ability of plasma to affect endothelial cell migration and vascular structure formation and for the presence of antiangiogenic activity.Results. Exposure of normal human microvascular dermal endothelial cells to plasma from patients with SSc resulted in decreased cell migration (mean ؎ SEM 52 ؎ 5%) and tube formation (34 ؎ 6%) compared with that in plasma from control patients (P < 0.001 for both). SSc plasma contained 2.9-fold more plasminogen kringle 1-3 fragments (angiostatin) than that in control plasma. The addition of angiostatin to control plasma resulted in inhibition of endothelial cell migration and proliferation similar to that observed in SSc plasma. In vitro studies demonstrated that granzyme B and other proteases contained in T cell granule content cleave plasminogen and plasmin into angiostatin fragments.Conclusion. Plasminogen conformation in patients with SSc enables granzyme B and granule content protease to limit the proangiogenic effects of plasmin and increase the levels of antiangiogenic angiostatin. This increase in angiostatin production may account for some of the vascular defects observed in patients with SSc.
“…Among those reported are various MMPs (17)(18)(19) and plasmin reductase (20,21). Granzyme B, a serine protease found in T cell granules, is strikingly associated with cleavage of autoantigens targeted by autoantibodies in patients with SSc (33,56). In agreement with this hypothesis, we demonstrated that both granzyme B and the full granule content could indeed cleave plasminogen into varioussized fragments containing angiostatin K [1][2][3] .…”
Section: Discussionsupporting
confidence: 63%
“…Although several proteases can potentially cleave plasminogen in a manner that would lead to angiostatin production, granzyme B is a particularly interesting candidate given its high levels in the peripheral blood cells of some patients with SSc (32,33). To determine whether granzyme B can cleave plasminogen, SSc and control plasma samples were allowed to interact with granzyme B or the entire granule content (the source of granzyme B) in vitro ( Figure 2C).…”
Section: Angiogenesis Inhibitors In Systemic Sclerosis 3451mentioning
Objective. Systemic sclerosis (SSc; scleroderma) is a systemic connective tissue disease with an extensive vascular component that includes aberrant microvasculature and impaired wound healing. The aim of this study was to investigate the presence of antiangiogenic factors in patients with SSc.Methods. Plasma samples were obtained from 30 patients with SSc and from 10 control patients without SSc. The samples were analyzed for the ability of plasma to affect endothelial cell migration and vascular structure formation and for the presence of antiangiogenic activity.Results. Exposure of normal human microvascular dermal endothelial cells to plasma from patients with SSc resulted in decreased cell migration (mean ؎ SEM 52 ؎ 5%) and tube formation (34 ؎ 6%) compared with that in plasma from control patients (P < 0.001 for both). SSc plasma contained 2.9-fold more plasminogen kringle 1-3 fragments (angiostatin) than that in control plasma. The addition of angiostatin to control plasma resulted in inhibition of endothelial cell migration and proliferation similar to that observed in SSc plasma. In vitro studies demonstrated that granzyme B and other proteases contained in T cell granule content cleave plasminogen and plasmin into angiostatin fragments.Conclusion. Plasminogen conformation in patients with SSc enables granzyme B and granule content protease to limit the proangiogenic effects of plasmin and increase the levels of antiangiogenic angiostatin. This increase in angiostatin production may account for some of the vascular defects observed in patients with SSc.
“…We cannot exclude the possibility that gzmB directly processes c-gelsolin in specific subtypes of cells. For example, the B23 autoantigen is most susceptible to cleavage by gzmB in differentiated smooth muscle cells (42).…”
“…Autoantibodies against B23, a cleavage product of a nuclear protein produced by the T cell enzyme granzyme B, can distinguish the subset of patients with scleroderma who also have PAH from patients with scleroderma without PAH (111). The mechanistic significance of this biomarker is not known.…”
Section: The Proinflammatory State Of the Vessel Wall And Pahmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.